ACTRN12613000337774终止1 期
Pilot Study of partially Human Leucocyte Antigen (HLA)-mismatched stem cell infusions after chemotherapy for acute myeloid leukaemia in patients over the age of 60: an evaluation of incidence of Graft vs Host Disease and treatment related mortality.
St Vincent's Hospital, Sydney0 个研究点目标入组 12 人开始时间: 2013年3月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 终止
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 60 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Patients aged over 60 with previously untreated AML undergoing induction chemotherapy, who have an available partially HLA-mismatched donor
排除标准
- •Patient with Acute Promyelocytic Leukaemia, Chronic Myeloid Leukaemia or unfit for induction chemotherapy or have immunodeficiency (apart from neutropenia)
研究者
相似试验
招募中
1 期
Multi Tumor-Associated Antigen-Specific T Lymphocytes to Treat Patients With High Risk Solid TumorsSolid TumorNCT05238792Children's National Research Institute24
已完成
不适用
Phase II study of Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy for maintenance of Patients With Neovascular Maculopathyeovascular MaculopathyJPRN-UMIN000006372Department of Ophthalmology, Osaka University Medical School120
进行中（未招募）
不适用
Trial aimed at evaluating the activity of the anti-ALK1 monoclonal antibody PF-03446962 in relapsed or refractory urothelial cancer (UC) failing first-line treatment.EUCTR2011-005983-12-ITISTITUTO NAZIONALE PER LA CURA TUMORI
已完成
不适用
Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 VaccineCOVID-19 PandemicNCT05158855DreamTec Research Limited16
已完成
不适用
A Trial to Establish the Role of Leukocyte Concentration and Tissue Type of Transfused Blood in Immunomodulation of Patients Undergoing Elective Surgery for Colorectal CancerCancerColorectal cancerISRCTN92341395eicester General Hospital (UK)